BG
ABMD

Bellevue Group’s Abiomed Inc ABMD Stock Holding History

Bellevue Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-166,355
Closed -$40.9M – 183
2022
Q3 		$40.9M Sell
166,355
-3,154
-2% -$852K 0.59% 51
2022
Q2 		$42M Buy
169,509
+19,331
+13% +$5.22M 0.59% 53
2022
Q1 		$49.7M Hold
150,178
– – 0.58% 58
2021
Q4 		$53.9M Sell
150,178
-1,000
-0.7% -$338K 0.56% 62
2021
Q3 		$49.2M Hold
151,178
– – 0.5% 64
2021
Q2 		$47.2M Buy
151,178
+8,494
+6% +$2.61M 0.46% 68
2021
Q1 		$45.5M Buy
142,684
+35,127
+33% +$11.2M 0.48% 67
2020
Q4 		$34.9M Buy
107,557
+6,159
+6% +$1.7M 0.4% 72
2020
Q3 		$28.1M Buy
101,398
+4,699
+5% +$1.35M 0.39% 71
2020
Q2 		$23.4M Sell
96,699
-11,373
-11% -$2.28M 0.33% 72
2020
Q1 		$15.7M Buy
108,072
+20,233
+23% +$3.36M 0.3% 67
2019
Q4 		$15M Sell
87,839
-45,192
-34% -$8.38M 0.24% 74
2019
Q3 		$23.7M Sell
133,031
-1,651
-1% -$357K 0.44% 52
2019
Q2 		$35.1M Buy
134,682
+75,293
+127% +$20M 0.6% 44
2019
Q1 		$17M Buy
59,389
+20,567
+53% +$6.84M 0.93% 34
2018
Q4 		$12.6M Buy
38,822
+5,687
+17% +$1.98M 0.83% 37
2018
Q3 		$14.9M Buy
33,135
+6,054
+22% +$2.39M 0.95% 36
2018
Q2 		$11.1M Sell
27,081
-169
-0.6% -$61.2K 0.94% 40
2018
Q1 		$7.93M Buy
27,250
+250
+0.9% +$63.4K 0.79% 49
2017
Q4 		$5.06M Sell
27,000
-58,110
-68% -$10.8M 0.53% 48
2017
Q3 		$14.3M Buy
85,110
+1,140
+1% +$172K 1.5% 19
2017
Q2 		$12M Buy
83,970
+20,300
+32% +$2.73M 1.42% 23
2017
Q1 		$7.97M Buy
63,670
+18,620
+41% +$2.16M 1.06% 37
2016
Q4 		$5.08M Sell
45,050
-10,400
-19% -$1.2M 1.04% 31
2016
Q3 		$7.13M Sell
55,450
-1,750
-3% -$210K 1.29% 28
2016
Q2 		$6.25M Buy
+57,200
New +$5.69M 1.18% 28

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Bellevue Group's ABMD Position: Q4 2022 in Review

Bellevue Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 166,355 shares — an estimated $40.9M sold.

Bellevue Group first reported a position in ABMD in Q2 2016 and held it in 26 quarters. The position peaked at $53.9M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bellevue Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bellevue Group sold 166,355 Abiomed Inc shares in Q4 2022, an estimated $40.9M.
  • Bellevue Group first reported a position in Abiomed Inc in Q2 2016 and held it in 26 quarters.
  • Bellevue Group's Abiomed Inc position peaked at $53.9M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bellevue Group's 13F filing for Q4 2022, filed 14 Feb 2023.